올리고뉴클레오티드 합성 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Oligonucleotide Synthesis Market size is expected to reach USD 14.81 Billion in 2034 from USD 4.72 Billion (2025) growing at a CAGR of 13.54% during 2026-2034.

The global oligonucleotide synthesis market has experienced strong growth due to increasing research in molecular biology and genetic studies. Oligonucleotides are short sequences of nucleotides that are synthesized for use in genetic research, diagnostics, and therapeutic development. These molecules play a crucial role in applications such as gene sequencing, polymerase chain reaction techniques, and targeted drug development.

Key drivers of the oligonucleotide synthesis market include the expansion of biotechnology and pharmaceutical research. Increasing investment in genetic therapies and personalized medicine has accelerated demand for high-quality synthetic oligonucleotides. Research institutions and pharmaceutical companies rely on these molecules for studying gene expression and developing innovative treatments.

Looking ahead, the oligonucleotide synthesis market is expected to grow as advances in genomics and biotechnology continue. Improvements in synthesis technologies and automation will enhance production efficiency and accuracy. As scientific research in genetics and molecular medicine expands, the demand for synthetic oligonucleotides will remain strong.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotides
• Equipment/Synthesizer
• Reagents
• Services

By Application

• PCR Primers
• PCR Assays and Panels
• Sequencing
• DNA Microarrays
• Fluorescence In Situ Hybridization (FISH)
• Antisense Oligonucleotides
• Other Applications

By End-use

• Academic Research Institutes
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Danaher, Revvity Discovery Limited, Agilent Technologies Inc, BioSynthesis Inc, Kaneka Eurogentec SA, LGC Biosearch Technologies, Biolegio, Twist Bioscience
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Equipment/Synthesizer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. PCR Primers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Assays and Panels Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. DNA Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Fluorescence In Situ Hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Antisense Oligonucleotides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OLIGONUCLEOTIDE SYNTHESIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Danaher
  • 9.2.4 Revvity Discovery Limited
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Bio-Synthesis Inc
  • 9.2.7 Kaneka Eurogentec S.A
  • 9.2.8 LGC Biosearch Technologies
  • 9.2.9 Biolegio
  • 9.2.10 Twist Bioscience